This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,093.50, is a delivery order for the supply of Telmisartan 20 mg tablets.
The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is the prime contractor, and the contract supports the medical care needs of military personnel, veterans, and other federal beneficiaries through the DLA's healthcare programs.
Generated 3/21/25, 9:52 AM